These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 27135533)

  • 21. Out-of-equilibrium dynamics of gene expression and the Jarzynski equality.
    Berg J
    Phys Rev Lett; 2008 May; 100(18):188101. PubMed ID: 18518416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Tumor Suppressor, P53, Decreases the Metal Transporter, ZIP14.
    Zhao N; Zhang AS; Wortham AM; Jue S; Knutson MD; Enns CA
    Nutrients; 2017 Dec; 9(12):. PubMed ID: 29292794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ChIP (chromatin immunoprecipitation) analysis demonstrates co-ordinated binding of two transcription factors to the promoter of the p53 tumour-suppressor gene.
    Polson A; Takahashi P; Reisman D
    Cell Biol Int; 2010 Sep; 34(9):883-91. PubMed ID: 20446924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of genes in the CA1 hippocampus region of adult rat following episodes of global ischemia.
    Yakubov E; Gottlieb M; Gil S; Dinerman P; Fuchs P; Yavin E
    Brain Res Mol Brain Res; 2004 Aug; 127(1-2):10-26. PubMed ID: 15306117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53-dependent suppression of uridine phosphorylase gene expression through direct promoter interaction.
    Zhang D; Cao D; Russell R; Pizzorno G
    Cancer Res; 2001 Sep; 61(18):6899-905. PubMed ID: 11559567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of p53 gene expression by a poxviral transcription factor.
    Wali A; Strayer DS
    Virology; 1996 Oct; 224(1):63-72. PubMed ID: 8862400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage.
    Kurdistani SK; Arizti P; Reimer CL; Sugrue MM; Aaronson SA; Lee SW
    Cancer Res; 1998 Oct; 58(19):4439-44. PubMed ID: 9766676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.
    Gomes NP; Bjerke G; Llorente B; Szostek SA; Emerson BM; Espinosa JM
    Genes Dev; 2006 Mar; 20(5):601-12. PubMed ID: 16510875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective transcription of p53 target genes by zinc finger-p53 DNA binding domain chimeras.
    Falke D; Fisher MH; Juliano RL
    Biochim Biophys Acta; 2004 Nov; 1681(1):15-27. PubMed ID: 15566940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential regulation of E2F transcription factors by p53 tumor suppressor protein.
    Vaishnav YN; Pant V
    DNA Cell Biol; 1999 Dec; 18(12):911-22. PubMed ID: 10619603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression profiles of p53-, p16(INK4a)-, and telomere-regulating genes in replicative senescent primary human, mouse, and chicken fibroblast cells.
    Kim H; You S; Farris J; Kong BW; Christman SA; Foster LK; Foster DN
    Exp Cell Res; 2002 Jan; 272(2):199-208. PubMed ID: 11777345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of Notch1 gene expression by p53 in epithelial cells.
    Yugawa T; Handa K; Narisawa-Saito M; Ohno S; Fujita M; Kiyono T
    Mol Cell Biol; 2007 May; 27(10):3732-42. PubMed ID: 17353266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Ews/Fli-1 fusion gene changes the status of p53 in neuroblastoma tumor cell lines.
    Rorie CJ; Weissman BE
    Cancer Res; 2004 Oct; 64(20):7288-95. PubMed ID: 15492248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage.
    Tanaka N; Ishihara M; Lamphier MS; Nozawa H; Matsuyama T; Mak TW; Aizawa S; Tokino T; Oren M; Taniguchi T
    Nature; 1996 Aug; 382(6594):816-8. PubMed ID: 8752276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The p53 protein induces stable miRNAs that have the potential to modify subsequent p53 responses.
    Cabrita MA; Bose R; Vanzyl EJ; Pastic A; Marcellus KA; Pan E; Hamill JD; McKay BC
    Gene; 2017 Apr; 608():86-94. PubMed ID: 28119089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA damage signalling recruits RREB-1 to the p53 tumour suppressor promoter.
    Liu H; Hew HC; Lu ZG; Yamaguchi T; Miki Y; Yoshida K
    Biochem J; 2009 Aug; 422(3):543-51. PubMed ID: 19558368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased GADD gene expression in human colon epithelial cells exposed to deoxycholate.
    Scott DW; Mutamba S; Hopkins RG; Loo G
    J Cell Physiol; 2005 Jan; 202(1):295-303. PubMed ID: 15316935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enforced expression of wild-type p53 curtails the transcription of the O(6)-methylguanine-DNA methyltransferase gene in human tumor cells and enhances their sensitivity to alkylating agents.
    Srivenugopal KS; Shou J; Mullapudi SR; Lang FF; Rao JS; Ali-Osman F
    Clin Cancer Res; 2001 May; 7(5):1398-409. PubMed ID: 11350911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple testing methods for ChIP-Chip high density oligonucleotide array data.
    Keleş S; van der Laan MJ; Dudoit S; Cawley SE
    J Comput Biol; 2006 Apr; 13(3):579-613. PubMed ID: 16706714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.